CervoMed Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $331.3K-96.6% YoYTTM through 30 Jun 2026
Net Income -$30.3MTTM through 30 Jun 2026
Free Cash Flow -$28MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 0.0% |
| Operating Margin | -9,407.0% |
| Net Margin | -9,160.9% |
Returns
-282.8%ROE
-198.8%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio3.36x
Net Debt-$12.9Mnet cash position
Cash & Equivalents$22.5M
Quality Metrics
Altman Z-Score-1.43
Piotroski F-Score2 / 9
FCF Margin-8,444.9%
Earnings-Beat Rate0.0%
Multi-Year Trend
RevenueFY2025: $4M
Diluted EPSFY2025: $-2.98
Dividend
No dividend
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.